CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Vetoquinol Sa Company Snapshot
Vetoquinol Sa operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vetoquinol Sa with three other pharmaceutical manufacturers in Europe: FAES Farma SA of SPAIN (2019 sales of 357.40 million Euros [US$422.46 million] of which 84% was Speciality Pharmaceuticals), Amarin Corporation PLC of UNITED KINGDOM (£335.97 million [US$435.76 million] of which 100% was Research&Development), and Biotest AG which is based in GERMANY (419.10 million Euros [US$495.39 million] of which 89% was Therapy).

Sales Analysis. During the year ended December of 2019, sales at Vetoquinol Sa were 395.99 million Euro (US$468.07 million). This is an increase of 7.6% versus 2018, when the company's sales were 367.94 million Euro. This was the fifth consecutive year of sales increases at Vetoquinol Sa (and since 2014, sales have increased a total of 26%). Sales of Americas saw an increase of 15.2% in 2019, from 128.31 million Euro to 147.80 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Vetoquinol Sa
  Stock Performance Chart for Vetoquinol Sa
 
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 68.60
(Figures in Euros )
1 Week -2.0%   13 Weeks -5.8%  
4 Weeks 13.2%   52 Weeks 25.2%  
 
Vetoquinol Sa Key Data:
  Ticker: VETO Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 395,990,000
(Year Ending Jan 2020).
Employees: 2,372
  Currency: Euros Market Cap: 811,446,213
  Fiscal Yr Ends: December Shares Outstanding: 11,828,662
  Share Type: Action Ordinaires Closely Held Shares: 7,950,213
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.